货号:A911451
同义名:
all-trans-Fucoxanthin
Fucoxanthin是一种从褐藻中提取的类胡萝卜素,通过激活 AMPK 信号通路促进脂肪分解,抑制脂肪生成。此外,Fucoxanthin能够通过诱导 ROS 生成和线粒体凋亡途径抑制肿瘤细胞的增殖。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Fucoxanthin is a natural product isolated and purified from the herbs of Laminaria japonica with antiobesity and antioxidative effects. |
| Concentration | Treated Time | Description | References | |
| Human dentin blocks | 50 µg/mL, 100 µg/mL, 200 µg/mL | 1 minute | To evaluate the inhibitory effect of Fucoxanthin on MMP activity, results showed decreased fluorescence intensity with increasing concentration, indicating MMP inhibition | Int J Nanomedicine. 2024 Dec 9;19:13253-13265 |
| Human dentin slices | 50 µg/mL, 100 µg/mL, 200 µg/mL | 10 minutes | To evaluate the effect of Fucoxanthin on dentin collagen cross-linking, results showed increased collagen cross-linking with shifts in amide II bands in a concentration-dependent manner | Int J Nanomedicine. 2024 Dec 9;19:13253-13265 |
| Caco-2 cells | 0.1, 1, 10, 50 µg/mL | 48 hours | Assessed metabolic activity and apoptotic activity, showing dose-dependent decrease in metabolic activity and increase in caspase 3/7 activity. | Antioxidants (Basel). 2019 Jun 19;8(6):183 |
| HepG2 cells | 0.1, 1, 10, 50 µg/mL | 48 hours | Assessed metabolic activity and apoptotic activity, showing dose-dependent decrease in metabolic activity and increase in caspase 3/7 activity. | Antioxidants (Basel). 2019 Jun 19;8(6):183 |
| HeLa cells | 0.1, 1, 10, 50 µg/mL | 24 hours | Assessed GSH/GSSG ratio, showing significant increase at 50 µg/mL. | Antioxidants (Basel). 2019 Jun 19;8(6):183 |
| RAW 264.7 cells | 0.1, 1, 10, 50 µg/mL | 24 hours | Assessed metabolic activity, showing significant decrease in RAW 264.7 cells metabolic activity at 50 µg/mL. | Antioxidants (Basel). 2019 Jun 19;8(6):183 |
| PBMCs | 0.1, 1, 10, 50 µg/mL | 24 hours | Assessed metabolic activity, showing no effect of Fucoxanthin on PBMCs metabolic activity up to 50 µg/mL. | Antioxidants (Basel). 2019 Jun 19;8(6):183 |
| Retinal Müller cells (RMCs) | 20 μg/mL | 24 hours | To evaluate the photoprotective effect of Fucoxanthin on UVB-induced RMCs, results showed that Fucoxanthin significantly reduced UVB-induced oxidative damage and improved cell viability. | Food Chem X. 2024 Jul 14;23:101648 |
| PC12 cells | 0.1–5 µM | 1 h pretreatment followed by 24 h exposure to Aβ25–35 | Fucoxanthin inhibited Aβ25-35-induced cell death by recovering cell cycle arrest and decreasing intracellular reactive oxygen species (ROS) level. | Antioxidants (Basel). 2023 Mar 3;12(3):629 |
| NIH/3T3 cells | 20 μM | 48 hours | Assess the effect of siTwist/FX@HES-CH on NIH/3T3 cells, showing inhibition of α-SMA expression. | J Adv Res. 2025 Apr;70:463-479 |
| 4T1 cells | 20 μM | 48 hours | Evaluate the cytotoxicity of siTwist/FX@HES-CH on 4T1 cells, showing significant synergistic anti-tumor effects. | J Adv Res. 2025 Apr;70:463-479 |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague Dawley rats | PAMP LPS-induced uveitis | Gavage | 0.1, 1, or 10 mg/kg BW | Once daily for 2 days | To investigate the anti-inflammatory effects of fucoxanthin on PAMP LPS-induced uveitis. The results showed that fucoxanthin significantly enhanced the expression of Nrf2, increased the activity of superoxide dismutase, and decreased the levels of malondialdehyde. It alleviated ocular hypertension, inflammatory cells, and proinflammatory cytokine TNF-α levels, preserved iris sphincter innervation and pupillary function, and inhibited corneal endothelial disruption. | Antioxidants (Basel). 2021 Jul 7;10(7):1092 |
| BALB/c mice | 4T1 orthotopic tumor model | Intravenous injection | 15 mg/kg FX and 1 mg/kg siTwist | Every 3 days for a total of 6 times | Evaluate the inhibitory effect of siTwist/FX@HES-CH on TNBC orthotopic tumors, showing significant reduction in tumor burden and inhibition of lung metastasis. | J Adv Res. 2025 Apr;70:463-479 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.52mL 0.30mL 0.15mL |
7.59mL 1.52mL 0.76mL |
15.18mL 3.04mL 1.52mL |
|
| CAS号 | 3351-86-8 |
| 分子式 | C42H58O6 |
| 分子量 | 658.91 |
| SMILES Code | CC(O[C@@H]1C[C@@](C)(O)C(C(C)(C)C1)=[C@]=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C(C[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)=O)=O |
| MDL No. | MFCD01745140 |
| 别名 | all-trans-Fucoxanthin |
| 运输 | 蓝冰 |
| InChI Key | SJWWTRQNNRNTPU-ABBNZJFMSA-N |
| Pubchem ID | 5281239 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 12 mg/mL(18.21 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1